Balance Sheet for Inovio Pharmaceuticals Inc. (INO)

$ 18.99 0.00 (0.00%) Volume: 1.5m 4:00 PM EDT Aug 10, 2020
Pre-Market:  $ 16.52   -2.47 (-13.01%) Volume: 1.5m 9:01 AM EDT Aug 11, 2020
Statement: View:
Assets [+] in Thousands of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Cash and Equivalents 22,196 23,694 23,787 19,136 57,633
Restrictable Cash - - - - -
Marketable Securities 67,338 57,539 103,639 85,629 105,357
Accounts Receivable 700 3,316 6,003 15,822 7,300
Loans Receivable - - - - -
Other Receivables - - - - -
Receivables 2,032 4,055 6,490 16,570 7,333
Inventories, Raw Materials - - - - -
Inventories, Work in Progress - - - - -
Inventories, Purchased Components - - - - -
Inventories, Finished Goods - - - - -
Inventories, Other - - - - -
Inventories, Adjustments & Allowances - - - - -
Inventories - - - - -
Prepaid Expenses 2,635 2,527 4,447 3,261 1,528
Current Deferred Income Taxes - - - - 1,028
Other Current Assets - - - - -
Total Current Assets 94,201 87,815 138,362 124,597 171,851
Land and Improvements - - - - -
Buildings and Improvement 15,008 14,909 14,554 5,248 3,572
Machinery, Furniture and Equipment 10,932 11,040 10,873 9,033 7,283
Construction in Progress - - - - -
Fixed Assets, Other 13,783 - - - -
Fixed Assets, Total 39,722 25,949 25,427 14,282 10,854
Gross Fixed Assets 39,722 25,949 25,427 14,282 10,854
Accumulated Depreciation (13,166) (10,000) (7,107) (5,256) (3,548)
Net Fixed Assets 26,556 15,949 18,320 9,025 7,307
Intangibles 3,694 4,760 6,010 7,628 3,906
Cost in Excess 10,513 10,513 10,513 10,513 10,113
Non-Current Deferred Income Taxes - - - - -
Other Non-Current Assets 2,672 2,670 2,639 2,113 671
Total Non-Current Assets 49,751 43,298 48,877 49,110 41,990
Total Assets 143,952 131,113 187,239 173,707 213,841
Liabilities [+] in Thousands of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Accounts Payable 7,649 11,022 8,492 6,993 4,457
Short Term Debt 2,075 - - - -
Notes Payable - - - - -
Accrued Expenses 15,368 18,763 24,326 20,046 11,373
Accrued Liabilities 15,368 18,763 24,326 20,046 11,373
Deferred Revenues 124 257 1,349 15,170 13,954
Current Deferred Income Taxes (261) - (150) (1) (2,084)
Other Current Liabilities 6,774 5,258 1,238 1,614 1,682
Total Current Liabilities 31,989 35,300 35,405 43,823 31,466
Long Term Debt 77,023 N/A N/A - -
Deferred Income Tax 32 25 25 175 176
Other Non-Current Liabilities 9,093 8,756 9,320 6,331 6,266
Minority Interest 1,970 96 96 96 246
Capital Lease Obligations 20,410 - - - -
Preferred Securities of Subsidiary Trust - - - - -
Preferred Equity Outside Shareholders' Equity - - - - -
Total Non-Current Liabilities 108,527 8,877 9,441 6,602 6,687
Total Liabilities 140,516 44,177 44,847 50,425 38,154
Preferred Shareholder's Equity - - - - -
Common Shareholder's Equity 3,435 86,936 142,393 123,282 175,687
Common Par 101 97 90 74 72
Additional Paid in Capital 742,647 707,794 665,776 556,718 534,005
Cumulative Translation Adjustments - - - - -
Retained Earnings (739,786) (620,426) (523,356) (434,838) (361,098)
Treasury Stock - - - - -
Other Equity Adjustments 473 (529) (117) 1,328 2,708
Total Capitalization 80,458 86,936 142,393 123,282 175,687
Total Equity 3,435 86,936 142,393 123,282 175,687
Total Liabilities & Shareholder's Equity 143,952 131,113 187,239 173,707 213,841
Cash Flow (126,070) (102,037) (91,995) (77,093) (31,370)
Working Capital 62,212 52,515 102,957 80,774 140,385
Free Cash Flow (98,838) (75,635) (73,503) (66,494) (15,220)
Invested Capital 80,458 86,936 142,393 123,282 175,687
Shares Outstanding - Common Class Only 101,361 97,226 90,358 74,062 72,218
Preferred Shares Outstanding 0 0 0 0 0
Total Ordinary Shares 101,361 97,226 90,358 74,062 72,218
Total Common Shares Outstanding 101,361 97,226 90,358 74,062 72,218
Treasury Shares - - - - -
Basic Weighted Shares Outstanding 98,718 92,540 81,777 73,215 68,198
Diluted Weighted Shares Outstanding 98,718 92,540 81,918 73,215 68,365